about provention bio________________

investors

 

   

 

MDB Capital Group finances development stage companies that possess meaningful technology that has the potential to impact large commercial markets and benefit humanity. MDB maximizes the value of these technology companies by helping position them to be the dominant leader in their technology domain and connecting them with a base of high-quality investors.

visit website >

 

 

The JDRF T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines into the hands of those living with T1D. The T1D Fund will invest in areas strategically aligned with JDRF, with an exclusive focus on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

visit website >

 

 

Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is focused on growing companies, not just investments. As the strategic venture capital arm of Johnson & Johnson, we pursue opportunities to solve critical healthcare needs. Our partners benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation.

visit website >